News
A life sciences company is setting up shop in Durham to take advantage of the area's robust talent pool and thriving biotech ...
Alexander Volkanovski is UFC featherweight champion once again. Volkanovski defeated Diego Lopes by unanimous decision in the ...
Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.
COMMENT: Almost overnight, the affable ‘Game of Thrones’ star seems to have become the most in-demand actor in Hollywood.
Vertex Pharmaceuticals slipped 1.41% to close at $475.49, managing to outperform a much gloomier market where the S&P 500 nose-dived 3.46%. Despite the drop, Vertex flexed its resilience, outpacing ...
5d
Zacks Investment Research on MSNVertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should KnowIn the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.
AskBio Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that its Board of Directors has elected Independent Director Laura Sepp-Lorenzino, PhD, to the ...
In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge loss for Vertex given that the company has a more advanced type 1 diabetes ...
It’s all in the eyes. They say that eyes are a window into your soul — but research shows they might also serve as an early window into cognitive decline. A study published in Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results